J. Blin

2.4k total citations
36 papers, 1.8k citations indexed

About

J. Blin is a scholar working on Cellular and Molecular Neuroscience, Neurology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J. Blin has authored 36 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cellular and Molecular Neuroscience, 13 papers in Neurology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J. Blin's work include Neuroscience and Neuropharmacology Research (11 papers), Parkinson's Disease Mechanisms and Treatments (11 papers) and Neurological disorders and treatments (9 papers). J. Blin is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Parkinson's Disease Mechanisms and Treatments (11 papers) and Neurological disorders and treatments (9 papers). J. Blin collaborates with scholars based in France, United States and Belgium. J. Blin's co-authors include Yves Agid, Jean‐Claude Baron, C. Crouzel, Muriel Bonnet, B. Pillon, Marco Fiorelli, Marie Vidailhet, Bruno Dubois, D. Attar-Lèvy and Bruno Dubois and has published in prestigious journals such as NeuroImage, Brain and Neurology.

In The Last Decade

J. Blin

36 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Blin France 23 780 707 446 376 258 36 1.8k
Joakim Tedroff Sweden 28 1.5k 1.9× 948 1.3× 381 0.9× 354 0.9× 162 0.6× 86 2.5k
C H van Dyck United States 9 968 1.2× 307 0.4× 355 0.8× 636 1.7× 314 1.2× 12 2.1k
K.A. Frey United States 13 585 0.8× 294 0.4× 332 0.7× 344 0.9× 146 0.6× 17 1.4k
Wynne K. Schiffer United States 27 1.1k 1.4× 225 0.3× 423 0.9× 268 0.7× 152 0.6× 50 1.9k
Wendy R. Galpern United States 26 1.3k 1.7× 1.3k 1.9× 502 1.1× 218 0.6× 97 0.4× 51 2.8k
Hanna Ruottinen Finland 25 711 0.9× 1.6k 2.2× 488 1.1× 258 0.7× 51 0.2× 40 2.2k
Mikko Kuoppamäki Finland 26 1.1k 1.4× 784 1.1× 363 0.8× 528 1.4× 203 0.8× 52 2.0k
Subrata K. Bose United Kingdom 14 343 0.4× 673 1.0× 379 0.8× 288 0.8× 93 0.4× 18 1.6k
Dieter Krell Germany 23 634 0.8× 163 0.2× 541 1.2× 361 1.0× 107 0.4× 44 1.7k
T. N. Chase United States 22 861 1.1× 959 1.4× 302 0.7× 282 0.8× 92 0.4× 54 1.7k

Countries citing papers authored by J. Blin

Since Specialization
Citations

This map shows the geographic impact of J. Blin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Blin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Blin more than expected).

Fields of papers citing papers by J. Blin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Blin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Blin. The network helps show where J. Blin may publish in the future.

Co-authorship network of co-authors of J. Blin

This figure shows the co-authorship network connecting the top 25 collaborators of J. Blin. A scholar is included among the top collaborators of J. Blin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Blin. J. Blin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldfarb, Lucas, Mohammad B. Chawki, J. Blin, et al.. (2022). Head-to-Head Comparison Between Rabbit Sign and EANM/SNMMI Criteria for the 18F-DOPA Visual Assessment of Parkinsonian Syndromes in PET/MRI. Clinical Nuclear Medicine. 48(2). 112–118. 1 indexed citations
2.
Attar-Lèvy, D., Jean‐Luc Martinot, J. Blin, et al.. (1999). The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine. Biological Psychiatry. 45(2). 180–186. 91 indexed citations
3.
Blin, J., Adrian Ivanoiu, Anne De Volder, et al.. (1998). Physostigmine results in an increased decrement in brain glucose consumption in Alzheimer's disease. Psychopharmacology. 136(3). 256–263. 9 indexed citations
4.
Volder, Anne De, Anne Bol, J. Blin, et al.. (1997). Brain energy metabolism in early blind subjects: neural activity in the visual cortex. Brain Research. 750(1-2). 235–244. 98 indexed citations
5.
Blin, J., Adrian Ivanoiu, Anne Bol, et al.. (1996). A study on blood flow and glucose consumption for the mapping of the brain cholinergic system in Alzheimer's disease. NeuroImage. 3(3). S571–S571. 2 indexed citations
6.
Durif, Franck, Marie Vidailhet, Muriel Bonnet, J. Blin, & Yves Agid. (1995). Levodopa-induced dyskinesias are improved by fluoxetine. Neurology. 45(10). 1855–1858. 89 indexed citations
7.
Blin, J., Barry Horwitz, Jean‐Claude Baron, & Yves Agid. (1995). Does frontal cortex hypometabolism in progressive supranuclear palsy result from subcortical dysfunction?. European Journal of Neurology. 1(3). 221–228. 8 indexed citations
8.
Blin, J., Bernard Mazoyer, S. Rivaud, et al.. (1995). Does the enhancement of cholinergic neurotransmission influence brain glucose kinetics and clinical symptomatology in progressive supranuclear palsy?. Brain. 118(6). 1485–1495. 26 indexed citations
9.
Pillon, B., J. Blin, M Vidailhet, et al.. (1995). The neuropsychological pattern of corticobasal degeneration. Neurology. 45(8). 1477–1483. 151 indexed citations
10.
Blin, J., Catherine A. Ray, Montford F. Piercey, et al.. (1994). Comparison of cholinergic drug effects on regional brain glucose consumption in rats and humans by means of autoradiography and positron emission tomography. Brain Research. 635(1-2). 196–202. 24 indexed citations
11.
Ray, C. George, J. Blin, Thomas N. Chase, & Montford F. Piercey. (1992). Effects of cholinergic agonists on regional brain energy metabolism in the scopolamine-treated rat. Neuropharmacology. 31(11). 1193–1199. 21 indexed citations
12.
Blin, J., et al.. (1992). Corticobasal degeneration: Decreased and asymmetrical glucose consumption as studied with PET. Movement Disorders. 7(4). 348–354. 70 indexed citations
13.
Mouradian, M. Maral, et al.. (1991). Somatostatin replacement therapy for alzheimer dementia. Annals of Neurology. 30(4). 610–613. 23 indexed citations
14.
Blin, J., Alain Denis, Takuji Yamaguchi, et al.. (1991). PET studies of [18F]methyl-MK-801, a potential NMDA receptor complex radioligand. Neuroscience Letters. 121(1-2). 183–186. 34 indexed citations
15.
Fiorelli, Marco, J. Blin, S. Bakchine, D Laplane, & Jean‐Claude Baron. (1991). PET studies of cortical diaschisis in patients with motor hemi-neglect. Journal of the Neurological Sciences. 104(2). 135–142. 82 indexed citations
16.
Blin, J.. (1990). Positron Emission Tomography Study in Progressive Supranuclear Palsy. Archives of Neurology. 47(7). 747–747. 164 indexed citations
17.
Blin, J., Giuliano Sette, Marco Fiorelli, et al.. (1990). A Method for the In Vivo Investigation of the Serotonergic 5‐HT2 Receptors in the Human Cerebral Cortex Using Positron Emission Tomography and 18F‐Labeled Setoperone. Journal of Neurochemistry. 54(5). 1744–1754. 85 indexed citations
18.
Baron, Jean‐Claude, J. L. Martinot, H Cambon, et al.. (1989). Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels. Psychopharmacology. 99(4). 463–472. 100 indexed citations
19.
Baron, Jean‐Claude, J. L. Martinot, H Cambon, et al.. (1989). Targets for Neurotransmitter Receptor Research Using PET Scan: The Neuroleptic Binding Site. PubMed. 7. 20–31. 1 indexed citations
20.
Pierot, Laurent, Claire Desnos, J. Blin, et al.. (1988). D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy. Journal of the Neurological Sciences. 86(2-3). 291–306. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joakim Tedroff Breakdown of academic impact, for papers by C H van Dyck Breakdown of academic impact, for papers by K.A. Frey Breakdown of academic impact, for papers by Wynne K. Schiffer Breakdown of academic impact, for papers by Wendy R. Galpern Breakdown of academic impact, for papers by Hanna Ruottinen Breakdown of academic impact, for papers by Mikko Kuoppamäki Breakdown of academic impact, for papers by Subrata K. Bose Breakdown of academic impact, for papers by Dieter Krell Breakdown of academic impact, for papers by T. N. Chase
Rankless by CCL
2026